Managing Director and Partner at Sinfonie Life Science Management GmbH and Chairman of the Board of Directors at Injex Pharma AG. Peter has a PhD in Biology and Chemistry from the Ludwig-Maximilians Universität in München and is co-founder and chairman of the executive board of BIO-Deutschland, an independent organization representing the interests of the German biotechnology industry. From 2001 to 2009 he was member of European Biopharmaceutical Enterprises (EBE), and its president from 2003 to 2006. He has been a Board Member of EuropaBio since June 2010, and a Member of the Board of Trustees of Bayern Innovativ GmbH. Peter is also a mentor and tutor at the Bavarian Elite Academy, and a member of the Supervisory Board of the University of Augsburg’s MBA program. LinkedIn
Dame Anne Glover
Scottish Biologist and academic. She was Professor of Molecular Biology and Cell Biology at the University of Aberdeen before being named Vice Principal for External Affairs and Dean for Europe. She also served as Chief Scientific Adviser to the President of the European Commission from 2012 to 2014. From 2006 to 2011, she was the Chief Scientific Adviser for Scotland. She is an elected Fellow of the Royal Society, Royal Society of Edinburgh, Society of Biology, Royal Society of Arts and the American Academy of Microbiology. Anne was recognised in March 2008 as a Woman of Outstanding Achievement in the UK and was awarded a CBE for services to Environmental Science in the Queen’s New Year Honours List 2009. She was elevated to DBE (Dame Commander of the Order of the British Empire) in the 2015 Birthday Honours List. Twitter
MEP Dr. Paul Ruebig
Austrian Member of the European Parliament since 1996, belonging to the European People’s Party (EPP). Paul is a full member of the Committee on Industry, Research and Energy and the Committee on Budgets, and is very active in the field of the small-scale business promotion. He is president of SME Global, a working group of the International Democrat Union (IDU), whose objective it is to support small and medium-sized enterprises and to improve their business environment. Since 2014, he has been the Chairman of STOA (Scientific Technology Options Assessment), an official body of the European Parliament that is supported by external experts such as universities, scientists or research institutes. Last but not least, he is Co-Chairman of the EPP medium-sized businesses in the Steering Committee on the WTO. LinkedIn
Ekaterina Smirnyagina is a partner with the Capricorn Health-Tech Venture Fund. Prior to this she was with Alta Partners, a US healthcare focused venture firm. Her current and past board memberships include Adocia (Euronext: ADOC.PA), ConfoTherapeutics NV, HalioDx SA, iSTAR Medical SA, Nexstim plc (Nasdaq First North: NXTMH.HE), Ablynx (Euronext: ABLX.BE), Cerenis Therapeutics (Euronext: CEREN.PA), Innate Pharma (Euronext: IPH.PA) and Kiadis Pharma (Euronext: KDS.AS), as well as InvestEurope (fka EVCA). She is the current Chair of the VC Council at InvestEurope. Previously Dr. Smirnyagina worked in business development at Genset S.A. and management consulting at the Mitchell Madison Group. She was a postdoctoral fellow in microbiology & immunology at the Stanford University School of Medicine and holds a Ph.D. in cellular & molecular biology from the University of Wisconsin-Madison and a B.Sc. in biochemistry from Moscow State University.
Secretary General of EuropaBio. John has nearly 30 years’ experience in the healthcare sector, the last thirteen of which being spent in the policy environment in Brussels, both working at the European Commission and in European trade associations for the healthcare industry. Prior to coming to Brussels he worked in the Irish National Standards Authority. Born in Ireland, John is a science graduate from Dublin, with added post-graduate studies in quality management and environmental engineering. LinkedIn
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.